Wealthfront Advisers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.1M Buy
244,488
+6,420
+3% +$899K 0.07% 95
2025
Q4
$29.2M Buy
238,068
+2,224
+0.9% +$270K 0.07% 101
2025
Q3
$26.2M Sell
235,844
-13,010
-5% -$1.48M 0.06% 100
2025
Q2
$27.6M Buy
248,854
+34,942
+16% +$3.72M 0.07% 89
2025
Q1
$24M Buy
213,912
+47,269
+28% +$4.88M 0.06% 93
2024
Q4
$15.4M Buy
166,643
+27,673
+20% +$2.49M 0.05% 124
2024
Q3
$11.7M Buy
138,970
+29,426
+27% +$2.25M 0.04% 146
2024
Q2
$7.52M Sell
109,544
-57,583
-34% -$3.84M 0.03% 191
2024
Q1
$12.2M Sell
167,127
-16,335
-9% -$1.26M 0.04% 130
2023
Q4
$14.9M Buy
183,462
+672
+0.4% +$52.3K 0.06% 96
2023
Q3
$13.7M Sell
182,790
-65,612
-26% -$5.05M 0.06% 92
2023
Q2
$19.1M Buy
248,402
+7,879
+3% +$628K 0.08% 69
2023
Q1
$20M Buy
240,523
+37,018
+18% +$3.07M 0.09% 60
2022
Q4
$17.5M Buy
203,505
+3,373
+2% +$267K 0.08% 64
2022
Q3
$12.3M Buy
200,132
+58,994
+42% +$3.72M 0.07% 76
2022
Q2
$8.72M Buy
141,138
+55,110
+64% +$3.41M 0.04% 109
2022
Q1
$5.12M Sell
86,028
-22,947
-21% -$1.47M 0.02% 205
2021
Q4
$7.91M Buy
108,975
+9,043
+9% +$623K 0.03% 127
2021
Q3
$6.98M Buy
99,932
+25,447
+34% +$1.79M 0.03% 121
2021
Q2
$5.13M Buy
74,485
+12,240
+20% +$817K 0.02% 135
2021
Q1
$4.02M Buy
62,245
+8,027
+15% +$518K 0.02% 142
2020
Q4
$3.16M Sell
54,218
-8,760
-14% -$529K 0.02% 138
2020
Q3
$3.98M Sell
62,978
-24,561
-28% -$1.7M 0.03% 97
2020
Q2
$6.74M Buy
87,539
+26,186
+43% +$2.01M 0.05% 69
2020
Q1
$4.59M Buy
61,353
+44,973
+275% +$3.11M 0.04% 75
2019
Q4
$1.06M Sell
16,380
-4,545
-22% -$296K 0.01% 309
2019
Q3
$1.33M Sell
20,925
-1,998
-9% -$131K 0.01% 235
2019
Q2
$1.55M Buy
22,923
+9,443
+70% +$621K 0.01% 193
2019
Q1
$876K Sell
13,480
-11,604
-46% -$771K 0.01% 280
2018
Q4
$1.57M Buy
+25,084
New +$1.75M 0.02% 163

Other funds holding GILD